Claris Lifesciences in talks with Otsuka Pharma for sale of injectables business : Reports

27 Nov 2012 Evaluate

Ahmedabad-based Claris Lifesciences is reported of having preliminary talks with Japanese Pharma company Otsuka Pharma for the sale of its injectables business. The valuation for the deal is likely to be in the range of $250 - $300 million, while IDFC and Barclays are the bankers. More than half of the revenue for Claris comes from the injectables business, which is also the key contributor of is growth.

Ahmedabad based, Claris Lifesciences offers injectibles in various therapeutic segments including anesthesia, critical care, anti-infectives, renal care, infusion therapy, parenteral nutrition and oncology. It has presence in 91 countries across Latin America, Europe, Gulf, Africa, CIS, Central Asia and Asia- Pacific.

Peers
Company Name CMP
Redington 268.50
Adani Enterprises 2265.10
Amrapali Industries 15.02
Rashi Peripheral 325.05
PDS 339.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×